Related Experiment Videos

[Invasive group A streptococcal infections in France]

M Robain1, S Baron, V Goulet

  • 1Hôpital National de Saint-Maurice.

Presse Medicale (Paris, France : 1983)
|September 23, 1995
PubMed
Abstract

Insights

Group A streptococci infections in France showed no increase in 2023, but streptococci shock syndrome is a significant concern due to its high mortality rate.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Epidemiology

Context:

  • Recent reports of necrotizing fasciitis in Great Britain prompted an investigation into Group A Streptococcus (GAS) infections in France.
  • The study aimed to assess the prevalence and clinical spectrum of GAS infections, focusing on necrotizing fasciitis.

Purpose:

  • To evaluate the frequency and severity of various clinical presentations of Group A Streptococcus infections in France.
  • To specifically assess the occurrence of necrotizing fasciitis within the broader context of GAS bacteremia.

Summary:

  • A study of 83 patients with Group A Streptococcus bacteremia in France (1993-1994) revealed underlying conditions in 63% and skin entry in 70%.
  • Clinical presentations included streptococci shock syndrome (16 cases), deep infections (13), soft tissue infections (25, including 3 fasciitis), and isolated bacteremia (29).
  • Mortality was 25%, with half of deaths in toxic shock syndrome patients. No increase in GAS or necrotizing fasciitis was observed compared to previous years.

Impact:

  • Identifies streptococci shock syndrome as a critical, high-mortality GAS presentation requiring attention.
  • Correlates mortality with patient age, health status, and clinical manifestation.
  • Provides baseline data on GAS infections in France, useful for future epidemiological surveillance.

Related Concept Videos